Brighten Optix (Taiwan) Today
6747 Stock | TWD 154.00 2.00 1.32% |
PerformanceOK
| Odds Of DistressLow
|
Brighten Optix is selling for under 154.00 as of the 19th of March 2025; that is 1.32% increase since the beginning of the trading day. The stock's lowest day price was 152.0. Brighten Optix has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 19th of March 2025. Click here to learn more.
Brighten Optix Corporation researches and develops, manufactures, and sells specialty contact lenses in Taiwan and the Asia Pacific region. The company offers its products under the Ortho-K myopia management lens, HiClear gas permeable lens, Briomoist lens care systems, SynergEyes hybrid lens, and Large Diameter GP lens. The company has 24.19 M outstanding shares. More on Brighten Optix
Moving together with Brighten Stock
0.8 | 3218 | Universal Vision Bio | PairCorr |
0.8 | 4104 | Excelsior Medical | PairCorr |
0.62 | 1788 | Hi Clearance | PairCorr |
Moving against Brighten Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Brighten Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Brighten Optix's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Brighten Optix or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business Concentration | Medical Devices, Healthcare (View all Sectors) |
Brighten Optix (6747) is traded on Taiwan OTC Exchange in Taiwan and employs 9 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.27 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Brighten Optix's market, we take the total number of its shares issued and multiply it by Brighten Optix's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Brighten Optix operates under Healthcare sector and is part of Medical Devices industry. The entity has 24.19 M outstanding shares.
Brighten Optix has accumulated about 681.19 M in cash with 204.74 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 28.16.
Check Brighten Optix Probability Of Bankruptcy
Ownership AllocationBrighten Optix holds a total of 24.19 Million outstanding shares. Brighten Optix shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 68.3 percent of Brighten Optix outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Brighten Ownership Details
Brighten Optix Risk Profiles
Although Brighten Optix's alpha and beta are two of the key measurements used to evaluate Brighten Optix's performance over the market, the standard measures of volatility play an important role as well.
Mean Deviation | 1.38 | |||
Semi Deviation | 1.52 | |||
Standard Deviation | 2.22 | |||
Variance | 4.93 |
Brighten Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Brighten Optix without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Economic Indicators Now
Economic IndicatorsTop statistical indicators that provide insights into how an economy is performing |
All Next | Launch Module |
Brighten Optix Corporate Management
Elected by the shareholders, the Brighten Optix's board of directors comprises two types of representatives: Brighten Optix inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Brighten. The board's role is to monitor Brighten Optix's management team and ensure that shareholders' interests are well served. Brighten Optix's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Brighten Optix's outside directors are responsible for providing unbiased perspectives on the board's policies.
Zheyu Li | Independent Director | Profile | |
Taixiong Wu | Chairman of the Board, General Manager | Profile | |
Guanhan Wu | General Manager of China Business-General Manager's Office, Director | Profile | |
Zhuyin Ye | Assistant General Manager of Finance & Accounting Center | Profile | |
Shifang Qiu | Independent Director | Profile | |
Zhiyuan You | Director | Profile |
Additional Tools for Brighten Stock Analysis
When running Brighten Optix's price analysis, check to measure Brighten Optix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brighten Optix is operating at the current time. Most of Brighten Optix's value examination focuses on studying past and present price action to predict the probability of Brighten Optix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brighten Optix's price. Additionally, you may evaluate how the addition of Brighten Optix to your portfolios can decrease your overall portfolio volatility.